|
Calumet Specialty Products Partners, L.P. (CLMT) DCF -Bewertung |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Calumet Specialty Products Partners, L.P. (CLMT) Bundle
Möchten Sie den inneren Wert von Calumet Specialty Products Partners, L.P., bestimmen? Unser (CLMT) DCF-Taschenrechner integriert reale Daten mit umfassenden Anpassungsfunktionen, sodass Sie Ihre Projektionen verfeinern und Ihre Anlagestrategien verbessern können.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,268.2 | 3,148.0 | 4,686.7 | 4,181.0 | 4,189.4 | 4,996.7 | 5,959.6 | 7,108.0 | 8,477.7 | 10,111.4 |
| Revenue Growth, % | 0.00 | 38.79 | 48.88 | -10.79 | 0.20 | 19.27 | 19.27 | 19.27 | 19.27 | 19.27 |
| EBITDA | 98.0 | 15.6 | 127.4 | 418.2 | 164.5 | 214.4 | 255.7 | 304.9 | 363.7 | 433.8 |
| EBITDA, % | 4.32 | 0.50 | 2.72 | 10.00 | 3.93 | 4.29 | 4.29 | 4.29 | 4.29 | 4.29 |
| Depreciation | 120.0 | 124.7 | 121.4 | 146.8 | 149.0 | 188.9 | 225.3 | 268.7 | 320.5 | 382.2 |
| Depreciation, % | 5.29 | 3.96 | 2.59 | 3.51 | 3.56 | 3.78 | 3.78 | 3.78 | 3.78 | 3.78 |
| EBIT | -22.0 | -109.1 | 6.0 | 271.4 | 15.5 | 25.5 | 30.4 | 36.3 | 43.2 | 51.6 |
| EBIT, % | -0.97 | -3.47 | 0.13 | 6.49 | 0.37 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| Total Cash | 109.4 | 38.1 | 35.2 | 7.9 | 38.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 160.4 | 253.0 | 244.7 | 286.2 | 278.1 | 337.8 | 402.9 | 480.5 | 573.1 | 683.5 |
| Account Receivables, % | 7.07 | 8.04 | 5.22 | 6.85 | 6.64 | 6.76 | 6.76 | 6.76 | 6.76 | 6.76 |
| Inventories | 254.9 | 326.6 | 498.0 | 439.4 | 416.3 | 526.7 | 628.1 | 749.2 | 893.6 | 1,065.7 |
| Inventories, % | 11.24 | 10.37 | 10.63 | 10.51 | 9.94 | 10.54 | 10.54 | 10.54 | 10.54 | 10.54 |
| Accounts Payable | 179.3 | 301.0 | 442.0 | 322.0 | 320.8 | 422.2 | 503.6 | 600.6 | 716.4 | 854.4 |
| Accounts Payable, % | 7.90 | 9.56 | 9.43 | 7.70 | 7.66 | 8.45 | 8.45 | 8.45 | 8.45 | 8.45 |
| Capital Expenditure | -44.0 | -82.9 | -536.2 | -271.8 | -76.7 | -243.3 | -290.2 | -346.2 | -412.9 | -492.4 |
| Capital Expenditure, % | -1.94 | -2.63 | -11.44 | -6.50 | -1.83 | -4.87 | -4.87 | -4.87 | -4.87 | -4.87 |
| Tax Rate, % | -0.91 | -0.55 | -1.67 | 3.21 | -0.65 | -0.11 | -0.11 | -0.11 | -0.11 | -0.11 |
| EBITAT | -22.2 | -109.7 | 6.1 | 262.7 | 15.6 | 25.5 | 30.4 | 36.3 | 43.3 | 51.6 |
| Depreciation | 120.0 | 124.7 | 121.4 | 146.8 | 149.0 | 188.9 | 225.3 | 268.7 | 320.5 | 382.2 |
| Changes in Account Receivables | -59.7 | -65.1 | -77.6 | -92.6 | -110.4 | |||||
| Changes in Inventories | -110.4 | -101.4 | -121.1 | -144.4 | -172.1 | |||||
| Changes in Accounts Payable | 101.4 | 81.4 | 97.0 | 115.8 | 138.0 | |||||
| Capital Expenditure | -44.0 | -82.9 | -536.2 | -271.8 | -76.7 | -243.3 | -290.2 | -346.2 | -412.9 | -492.4 |
| UFCF | -182.2 | -110.5 | -430.8 | 34.8 | 117.9 | -97.6 | -119.7 | -142.8 | -170.3 | -203.1 |
| WACC, % | 28.66 | 28.66 | 28.66 | 28.00 | 28.66 | 28.53 | 28.53 | 28.53 | 28.53 | 28.53 |
| PV UFCF | -75.9 | -72.4 | -67.3 | -62.4 | -57.9 | |||||
| SUM PV UFCF | -335.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -207.2 | |||||||||
| Terminal Value | -780.9 | |||||||||
| Present Terminal Value | -222.6 | |||||||||
| Enterprise Value | -558.5 | |||||||||
| Net Debt | 238.0 | |||||||||
| Equity Value | -796.5 | |||||||||
| Diluted Shares Outstanding, MM | 83.0 | |||||||||
| Equity Value Per Share | -9.60 |
What You Will Get
- Real CLMT Financial Data: Pre-filled with Calumet Specialty Products Partners' historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See CLMT's intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Real-Life CLMT Data: Pre-filled with Calumet Specialty Products Partners' historical financials and future projections.
- Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Testing: Develop multiple forecasting scenarios to evaluate various valuation results.
- User-Friendly Design: Intuitive, organized, and tailored for both professionals and novices.
How It Functions
- Download the Template: Gain immediate access to the Excel-based CLMT DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and more.
- Instant Calculations: The model automatically recalculates Calumet's intrinsic value.
- Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis.
Why Choose This Calculator for Calumet Specialty Products Partners, L.P. (CLMT)?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and industry consultants.
- Comprehensive Data: Calumet’s historical and projected financials preloaded for precision.
- Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Insightful Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Clear, step-by-step instructions to navigate the calculation process.
Who Should Use This Product?
- Investors: Accurately assess Calumet Specialty Products Partners, L.P.'s (CLMT) fair value prior to making investment choices.
- CFOs: Utilize a high-quality DCF model for financial reporting and analysis specific to CLMT.
- Consultants: Efficiently modify the template for valuation reports tailored to CLMT clients.
- Entrepreneurs: Acquire knowledge about financial modeling practices employed by leading companies like Calumet.
- Educators: Implement it as an educational resource to illustrate valuation techniques relevant to CLMT.
What the Template Contains
- Historical Data: Includes Calumet Specialty Products Partners, L.P. (CLMT)’s past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Calumet Specialty Products Partners, L.P. (CLMT)’s intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Calumet Specialty Products Partners, L.P. (CLMT)’s financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.